Transfer of Nimodipine and Another Calcium Antagonist Across the Blood-Brain Barrier and Their Regional Distribution In Vivo

[1]  P. Raskin.  Islet-cell abnormalities in non-insulin-dependent diabetes mellitus. , 1985, The American journal of medicine.

[2]  H. Glossmann,et al.  The molecular pharmacology and structural features of calcium channels. , 1985, British journal of clinical pharmacology.

[3]  H. Glossmann,et al.  (−)-3H-desmethoxyverapamil labelling of putative calcium channels in brain: autoradiographic distribution and allosteric coupling to 1,4-dihydropyridine and diltiazem binding sites , 1984, Naunyn-Schmiedeberg's Archives of Pharmacology.

[4]  H. Yamamura,et al.  High affinity specific [3H](+)PN 200-110 binding to dihydropyridine receptors associated with calcium channels in rat cerebral cortex and heart. , 1984, Life sciences.

[5]  J. Palacios,et al.  The effects of lesions in the rat hippocampus suggest the association of calcium channel blocker binding sites with specific neuronal population , 1983, Neuroscience Letters.

[6]  R. Quirion.  Autoradiographic localization of a calcium channel antagonist, [3H]nitrendipine, binding site in rat brain , 1983, Neuroscience Letters.

[7]  R. Towart,et al.  Dihydropyridine receptor in rat brain labeled with [3H]nimodipine. , 1983, Proceedings of the National Academy of Sciences of the United States of America.

[8]  H. Schoemaker,et al.  In vivo identification of calcium antagonist binding sites using [3H]nitrendipine. , 1983, European journal of pharmacology.

[9]  Ronald G. Blasberg,et al.  Transport of α-Aminoisobutyric Acid across Brain Capillary and Cellular Membranes , 1983 .

[10]  C S Patlak,et al.  Graphical Evaluation of Blood-to-Brain Transfer Constants from Multiple-Time Uptake Data , 1983, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[11]  S. Yalkowsky.  Topics in Pharmaceutical Sciences , 1983 .

[12]  A. Fleckenstein.  History of Calcium Antagonists , 1983, Circulation research.

[13]  J. Patel,et al.  Specific calcium antagonist binding sites in brain. , 1982, Life sciences.

[14]  H. Yamamura,et al.  The interaction of [3H]nitrendipine with receptors for calcium antagonists in the cerebral cortex and heart of rats. , 1982, Biochemical and biophysical research communications.

[15]  S. Snyder,et al.  Calcium antagonists receptor sites labeled with [3H]nitrendipine , 1982 .

[16]  P. Grinwald,et al.  Calcium entry blockers and myocardial function. , 1981, Federation proceedings.

[17]  B. Siesjö.  Cell Damage in the Brain: A Speculative Synthesis , 1981, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[18]  J. Farber,et al.  Myocardial ischemia: the pathogenesis of irreversible cell injury in ischemia. , 1981, The American journal of pathology.

[19]  A. Gjedde,et al.  Blood–Brain Glucose Transport in the Conscious Rat: Comparison of the Intravenous and Intracarotid Injection Methods , 1980, Journal of neurochemistry.

[20]  A. Gjedde,et al.  Pentobarbital Anesthesia Reduces Blood–Brain Glucose Transfer in the Rat , 1980, Journal of neurochemistry.

[21]  A. Gjedde,et al.  Rapid simultaneous determination of regional blood flow and blood-brain glucose transfer in brain of rat. , 1980, Acta physiologica Scandinavica.

[22]  A. Gjedde,et al.  Rapid steady-state analysis of blood-brain glucose transfer in rat. , 1980, Acta physiologica Scandinavica.

[23]  T. Godfraind.  Alternative mechanisms for the potentiation of the relaxation evoked by isoprenaline in aortae from young and aged rats. , 1979, European journal of pharmacology.

[24]  K D Pettigrew,et al.  Lower limits of cerebrovascular permeability to nonelectrolytes in the conscious rat. , 1978, The American journal of physiology.

[25]  C S Patlak,et al.  Measurements of dog blood-brain transfer constants by ventriculocisternal perfusion. , 1975, The American journal of physiology.

[26]  K. Go,et al.  The dependence of the blood to brain passage of radioactive sodium on blood pressure and temperature , 1975, Brain Research.

[27]  G Baños,et al.  The influx of amino acids into the brain of the rat in vivo: the essential compared with some non-essential amino acids , 1973, Proceedings of the Royal Society of London. Series B. Biological Sciences.

[28]  C. Kleeman,et al.  Stability of the potassium content of cerebrospinal fluid and brain. , 1967, The American journal of physiology.

[29]  C Crone,et al.  The permeability of brain capillaries to non-electrolytes. , 1965, Acta physiologica Scandinavica.

[30]  C. Crone,et al.  THE PERMEABILITY OF CAPILLARIES IN VARIOUS ORGANS AS DETERMINED BY USE OF THE 'INDICATOR DIFFUSION' METHOD. , 1963, Acta physiologica Scandinavica.

[31]  Ulrich Friedemann,et al.  BLOOD-BRAIN BARRIER , 1942 .

[32]  A. Katz,et al.  Cellular actions and pharmacology of the calcium channel blocking drugs. , 1984, The American journal of medicine.

[33]  A. Scriabine.  New drugs annual : cardiovascular drugs , 1983 .

[34]  R. Towart,et al.  The effects of nimodipine, its optical isomers and metabolites on isolated vascular smooth muscle. , 1982, Arzneimittel-Forschung.

[35]  B. Garthoff,et al.  Cerebrovascular effects of the calcium antagonistic dihydropyridine derivative nimodipine in animal experiments. , 1982, Arzneimittel-Forschung.

[36]  H. Krause,et al.  Behavioral effects of nimodipine in animals. , 1982, Arzneimittel-Forschung.

[37]  C S Patlak,et al.  Methods for Quantifying the transport of drugs across brain barrier systems. , 1981, Pharmacology & therapeutics.